Literature DB >> 12378361

Hemi-corticotomy in the management of chronic osteomyelitis of the tibia.

Khaled M Emara1.   

Abstract

We reviewed 20 cases of chronic osteomyelitis of the tibial diaphysis without shortening or deformity resulting from different causes. Debridement included removal of the anterior half of the tibial cortex with any sequestrum, leaving the posterior cortex intact with its vascular muscle attachments. This was then followed by hemi-corticotomy (hemi-circumferential corticotomy and partial bone fragment transfer) in order to reconstruct the resulting defect. This technique proved effective in 19 out of the 20 patients. Follow-up was by plain radiography and sedimentation rate estimations, with an average follow-up of 34 months after operation. In nine patients, early removal of the fixation frame immediately after segment transfer followed by cast application produced the same outcome as achieved with patients in whom the frame remained in position until the end of the procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12378361      PMCID: PMC3620990          DOI: 10.1007/s00264-002-0374-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  4 in total

1.  Methods to shorten the duration of an external fixator in the management of tibial infections.

Authors:  Khaled M Emara; Khaled Abd Al Ghafar; Mohamed Ahmed Al Kersh
Journal:  World J Orthop       Date:  2011-09-18

2.  Cost of external fixation vs external fixation then nailing in bone infection.

Authors:  Khaled Mohamed Emara; Ramy Ahmed Diab; Khaled Abd El Ghafar
Journal:  World J Orthop       Date:  2015-01-18

3.  Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, vancomycin beads and systemic antibiotics.

Authors:  Hakan Kinik; Mert Karaduman
Journal:  Int Orthop       Date:  2007-03-21       Impact factor: 3.075

4.  Pelvic support osteotomy in the treatment of patients with excision arthroplasty.

Authors:  Khaled Mohamed Emara
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.